Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

There are currently no approved therapeutics or vaccines to treat or protect against the severe hemorrhagic fever and death caused by Ebola virus (EBOV). Ebola virus-like particles (EBOV VLPs) consisting of the matrix protein VP40, the glycoprotein (GP), and the nucleoprotein (NP) are highly immunog...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Virol
Egile Nagusiak: Schweneker, Marc, Laimbacher, Andrea S., Zimmer, Gert, Wagner, Susanne, Schraner, Elisabeth M., Wolferstätter, Michael, Klingenberg, Marieken, Dirmeier, Ulrike, Steigerwald, Robin, Lauterbach, Henning, Hochrein, Hubertus, Chaplin, Paul, Suter, Mark, Hausmann, Jürgen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2017
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432887/
https://ncbi.nlm.nih.gov/pubmed/28331098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00343-17
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak